Is Miglitol compatible with breastfeeding? Do we have alternatives for Miglitol?
Miglitol
August 6, 2017 (Very Low Risk)
Alpha-glucosidase inhibitor which acts within the gastrointestinal tract without being absorbed, reducing intestinal absorption of glucose. Very low risk of hypoglycemia in monotherapy.
Miglitol is excreted in breast milk in minute quantities (Serrano 2014, Pfizer 2012, AEMPS 2009) reaching a relative dose much less than 1%.
Diet, exercise, and breastfeeding improve blood sugar levels.
See below the information of this related product:
- Maternal Diabetes Mellitus (Low Risk probable)
Alternatives
- Sport (Very Low Risk)
- Hypo-Caloric Diet (Very Low Risk)
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Writings
- ميغليتول (Arabic)
- Миглитол (Cyrillic)
- 米格列醇 (Chinese)
- ミグリトール (Japanese)
- C8H17NO5 (Molecular formula)
References
- Serrano Aguayo P, García de Quirós Muñoz JM, Bretón Lesmes I, Cózar León MV. Tratamiento de enfermedades endocrinológicas durante la lactancia. [Endocrinologic diseases management during breastfeeding.] Med Clin (Barc). 2015Abstract